BPPT Prepares Antigen And Antibody Test Devices

JAKARTA - The Agency for the Assessment and Application of Technology (BPPT) prepares antigen and antibody test devices to support post-vaccination examination of COVID-19.

"This will be a complement to the process of screening and testing COVID-19, complementing our needs that are still imported," said HEAD of BPPT Hammam Riza in Jakarta, as quoted by Antara, Thursday, May 20.

According to him, both inspection devices are targeted to be usable starting June 2021.

BPPT developed an immunofluorescence assay (IFA) based antibody test device with Bio Farma and biomedical experts. The tool to measure the level of post-vaccination antibodies is still in the testing stage.

In addition to developing examination tools, BPPT makes immunity-enhancing supplements from fermented garlic extracts and multi-vitamin biscuits that can help boost immunity.